Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Cirrhosis, Hepatitis B, Hepatitis C
Interventions: FibroScan; Device
Lead sponsor: Afdhal, Nezam, M.D.; Individual
Eligibility: 18 Years to 90 Years
Enrollment: 907 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 3
States / cities: Boston, Massachusetts • St Louis, Missouri • Durham, North Carolina

Conditions: Wellness, Self Compassion, Burnout, Anxiety, Depression
Interventions: App-based bundled mental fitness intervention, App-based wellness module collection; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Depression, Anxiety
Interventions: Quetiapine-XR; Drug
Lead sponsor: Loyola University; Other
Eligibility: 20 Years to 65 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Renal Failure, End Stage Renal Disease, Hemodialysis, Vascular Access
Interventions: Human Acellular Vessel (HAV), ePTFE graft; Biological · Device
Lead sponsor: Humacyte, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 355 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 22
States / cities: Phoenix, Arizona • Tucson, Arizona • Fresno, California + 18 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Exenatide, Albiglutide; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Louisville, Kentucky • Dallas, Texas

Conditions: Overweight, Obesity
Interventions: Switch active lifestyles brought to you by MediaWise, Switch active lifestyles from MediaWise; Behavioral
Lead sponsor: National Institute on Media and the Family; Other
Eligibility: 8 Years to 13 Years
Enrollment: 1,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Parkinson Disease, Essential Tremor
Interventions: Ultrasound Imaging, Electromyography, Inertial Measurement Units (IMU), Functional Electrical Stimulation (FES); Device
Lead sponsor: North Carolina State University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Trauma-related PTSD, Anxiety and Distress, Depression
Interventions: Healing Trauma Plus (HT+): A Brief Intervention for Women and Gender-Diverse People; Behavioral
Lead sponsor: Envisioning Justice Solutions, Inc; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chowchilla, California

Conditions: Macular Edema Associated With Diabetes Mellitus
Interventions: Standard of Care, Macugen; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 28
States / cities: Phoenix, Arizona • Tucson, Arizona • Los Angeles, California + 24 more

Conditions: Basal Cell Carcinoma
Interventions: 5% Imiquimod cream, Placebo Vehicle Control Cream; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 1,630 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2032
U.S. locations: 8
States / cities: Long Beach, California • San Diego, California • Bay Pines, Florida + 5 more

Conditions: Risk Behavior, HIV/AIDS, Medication Adherence, Substance Abuse
Interventions: CHRP-BB; Other
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years and older
Enrollment: 237 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Placebo, SPN-812; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 37
States / cities: Garden Grove, California • Los Alamitos, California • Newport Beach, California + 32 more

Conditions: Asthma
Interventions: Pneumonococcal Polysaccharide Vaccine 23-valent (PPSV-23); Biological
Lead sponsor: Rohit Divekar; Other
Eligibility: 19 Years to 20 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Diabetes Mellitus, Type 2
Interventions: albiglutide, sitagliptin, glimepiride, metformin, placebo albiglutide, placebo sitagliptin, placebo glimepiride; Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 1,049 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 317
States / cities: Birmingham, Alabama • Dothan, Alabama • Hueytown, Alabama + 254 more

Conditions: Anorexia Nervosa
Interventions: Quetiapine, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Mental Health Issue, Mental Health Disorder, Stress, Emotional, Economic Problems
Interventions: Refugee and Immigrant Well-being Project (RIWP); Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 1,212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Graves' Disease
Interventions: Felzartamab, Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 14
States / cities: Glendale, Arizona • Los Angeles, California • San Jose, California + 11 more

Conditions: Osteoarthritis, Osteo Arthritis Knee
Interventions: Colchicine 0.8 mg or 0.6 mg orally once daily, Placebo oral capsule; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Compliance With Restrictive RBC Transfusion Guideline
Interventions: Feedback; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: Not listed
Enrollment: 426 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 5
States / cities: Boston, Massachusetts • Minneapolis, Minnesota • St Louis, Missouri + 2 more

Conditions: Ankle Arthritis, Ankle Arthropathy
Interventions: Intra-articular injection, Peripheral nerve block; Procedure
Lead sponsor: Slocum Research & Education Foundation; Other
Eligibility: 40 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Osteoarthritis, Hip
Interventions: isobaric bupivacaine, hyperbaric bupivacaine, isobaric mepivacaine; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 84 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Bensalem, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Tooth Loss, Peri-implant Mucosa Defect
Interventions: Acellular Dermal Matrix, Autologous subepithelial connective tissue graft; Drug · Procedure
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Chemotherapy-induced Peripheral Neuropathy (CIPN)
Interventions: Auricular Point Acupressure, Control Auricular Point Acupressure-; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Drug-Resistant Epilepsy, Epilepsy, Epilepsy (Treatment Refractory), Epilepsy Comorbidities, Epilepsy, Drug Resistant, Epilepsy, Generalized, Epilepsy, Focal
Interventions: Target optimization using LIFU, Serial LIFU stimulation; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

A Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion

Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis

An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects

Healthy Futures Project: A Community Based Obesity Prevention Program

Analysis and Suppression of Tremor During Grasp Using Ultrasound Imaging and Electrical Stimulation

Healing Trauma Plus

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Basal Cell Carcinoma Chemoprevention Trial

Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

Trial of Quetiapine in Anorexia Nervosa

Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

Colchicine for the Treatment of Osteoarthritis of the Knee

Trial of Feedback on Blood Use

Peripheral Nerve Block Compared to Intra-articular Injection for TAA Post-operative Pain

3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty

Comparison of Two Different Surgical Approaches To Increase Peri-Implant Mucosa Thickness

Auricular Point Acupressure: Examining the Scientific Underpinnings of Pain Relief

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy